GB

Matthew Paul Baker

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Paul Baker. Retrieved from https://idiyas.com/inventor/matthew-paul-baker-gn0q89zp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Matthew Paul Baker - Innovator in Human Antibodies and Proteins

Introduction

Matthew Paul Baker is a notable inventor based in Great Britain. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies and proteins. His work focuses on creating composite proteins that exhibit reduced immunogenicity, which is crucial for therapeutic applications.

Latest Patents

Matthew Paul Baker currently holds no patents. However, his notable invention involves composite proteins, including antibodies that have been modified to remove one or more T-cell epitopes. This innovation aims to enhance the safety and efficacy of antibodies used in human treatments.

Career Highlights

Matthew is associated with Antitope Limited, a company that specializes in the development of biopharmaceuticals. His expertise in antibody engineering has positioned him as a valuable asset in the field. He has worked diligently to advance the understanding and application of human antibodies in medical science.

Collaborations

Matthew collaborates with Timothy David Jones, contributing to the innovative projects at Antitope Limited. Their combined efforts aim to push the boundaries of antibody technology and improve therapeutic outcomes.

Conclusion

Matthew Paul Baker is a dedicated inventor whose work in human antibodies and proteins has the potential to significantly impact the field of biotechnology. His contributions reflect a commitment to advancing medical science through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…